Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

1.96
Delayed Data
As of May 26
 -0.07 / -3.45%
Today’s Change
1.40
Today|||52-Week Range
18.60
-61.11%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close2.03
Today’s open2.10
Day’s range1.71 - 2.22
Volume192,122
Average volume (3 months)100,245
Market cap$4.7M
Dividend yield--
Data as of 3:56pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+10.85%
Earnings growth (this year)+55.65%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+523.06%
P/E ratio--
Price/Sales2.25
Price/Book0.17

Competitors

 Today’s
change
Today’s
% change
RGBPRegen BioPharma Inc+0.00+2.38%
ORPNBioblast Pharma Ltd-0.01-2.15%
XTNTXtant Medical Holdin...+0.01+1.33%
IGCIndia Globalization ...+0.01+2.96%
Data as of 4:02pm ET, 05/26/2017

Financials

Last reporting dateApril 3, 2017
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$8.3M
Annual profit (last year)-$17.3M
Net profit margin-209.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, Tel Aviv

Forecasts